MALARONE is a fixed dose combination product which acts as a blood schizonticide and also has activity against the hepatic forms of Plasmodium falciparum. It is indicated for: Prophylaxis of Plasmodium falciparum malaria.
Treatment of Plasmodium falciparum malaria.
Because MALARONE is effective against drug sensitive and drug resistant P. falciparum it is especially recommended for prophylaxis and treatment of P. falciparum malaria in areas where the pathogen may be resistant to other antimalarials.
Official guidelines and local information on the prevalence of resistance to antimalarial drugs should be taken into consideration. Official guidelines will normally include WHO and public health authorities guidelines.